ZOETIS INC (1ZTS.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1ZTS - US98978V1035 - Common Stock
1ZTS.MI Key Statistics, Chart & Performance
The current stock price of 1ZTS.MI is 107.18 EUR. In the past month the price decreased by -30.98%.
1ZTS.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1ZTS.MI.
1ZTS.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1ZTS.MI. Both the health and profitability get an excellent rating, making 1ZTS.MI a very profitable company, without any liquidiy or solvency issues.
1ZTS.MI Financial Highlights
Over the last trailing twelve months 1ZTS.MI reported a non-GAAP Earnings per Share(EPS) of 5.42. The EPS increased by 10.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.21% | ||
| ROA | 17.49% | ||
| ROE | 49.11% | ||
| Debt/Equity | 1.31 |
1ZTS.MI Forecast & Estimates
24 analysts have analysed 1ZTS.MI and the average price target is 141.62 EUR. This implies a price increase of 32.13% is expected in the next year compared to the current price of 107.18.
For the next year, analysts expect an EPS growth of 8.15% and a revenue growth 2.07% for 1ZTS.MI
1ZTS.MI Ownership
About 1ZTS.MI
Company Profile
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company Info
ZOETIS INC
10 Sylvan Way
Parsippany NEW JERSEY US
Employees: 13800
Phone: 19738227000
ZOETIS INC / 1ZTS.MI FAQ
What does ZOETIS INC do?
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 13,800 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Can you provide the latest stock price for ZOETIS INC?
The current stock price of 1ZTS.MI is 107.18 EUR. The price decreased by -1.11% in the last trading session.
Does 1ZTS stock pay dividends?
ZOETIS INC (1ZTS.MI) has a dividend yield of 1.64%. The yearly dividend amount is currently 1.49.
How is the ChartMill rating for ZOETIS INC?
1ZTS.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about ZOETIS INC (1ZTS.MI) stock?
24 analysts have analysed 1ZTS.MI and the average price target is 141.62 EUR. This implies a price increase of 32.13% is expected in the next year compared to the current price of 107.18.
What is ZOETIS INC worth?
ZOETIS INC (1ZTS.MI) has a market capitalization of 47.23B EUR. This makes 1ZTS.MI a Large Cap stock.